Endre søk
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Chromogranin-A Expression as a Novel Biomarker for Early Diagnosis of Colon Cancer Patients
Örebro universitet, Institutionen för medicinska vetenskaper. Centre for Systems Biology, Soochow University, Suzhou, China.ORCID-id: 0000-0001-5963-9261
Örebro universitet, Institutionen för medicinska vetenskaper.
Centre for Systems Biology, Soochow University, Suzhou, China.
Department of Oncology and Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.
2019 (engelsk)Inngår i: International Journal of Molecular Sciences, ISSN 1422-0067, E-ISSN 1422-0067, Vol. 20, nr 12, artikkel-id 2919Artikkel i tidsskrift (Fagfellevurdert) Published
Abstract [en]

Colon cancer is one of the major causes of cancer death worldwide. The five-year survival rate for the early-stage patients is more than 90%, and only around 10% for the later stages. Moreover, half of the colon cancer patients have been clinically diagnosed at the later stages. It is; therefore, of importance to enhance the ability for the early diagnosis of colon cancer. Taking advantages from our previous studies, there are several potential biomarkers which have been associated with the early diagnosis of the colon cancer. In order to investigate these early diagnostic biomarkers for colon cancer, human chromogranin-A (CHGA) was further analyzed among the most powerful diagnostic biomarkers. In this study, we used a logistic regression-based meta-analysis to clarify associations of CHGA expression with colon cancer diagnosis. Both healthy populations and the normal mucosa from the colon cancer patients were selected as the double normal controls. The results showed decreased expression of CHGA in the early stages of colon cancer as compared to the normal controls. The decline of CHGA expression in the early stages of colon cancer is probably a new diagnostic biomarker for colon cancer diagnosis with high predicting possibility and verification performance. We have also compared the diagnostic powers of CHGA expression with the typical oncogene KRAS, classic tumor suppressor TP53, and well-known cellular proliferation index MKI67, and the CHGA showed stronger ability to predict early diagnosis for colon cancer than these other cancer biomarkers. In the protein-protein interaction (PPI) network, CHGA was revealed to share some common pathways with KRAS and TP53. CHGA might be considered as a novel, promising, and powerful biomarker for early diagnosis of colon cancer.

sted, utgiver, år, opplag, sider
MDPI , 2019. Vol. 20, nr 12, artikkel-id 2919
Emneord [en]
CHGA, colon cancer, biomarker, early diagnosis, logistic regression, meta-analysis, PPI
HSV kategori
Identifikatorer
URN: urn:nbn:se:oru:diva-75234DOI: 10.3390/ijms20122919ISI: 000473756000069PubMedID: 31207989Scopus ID: 2-s2.0-85068403124OAI: oai:DiVA.org:oru-75234DiVA, id: diva2:1339069
Forskningsfinansiär
Swedish Cancer SocietySwedish Research CouncilTilgjengelig fra: 2019-07-25 Laget: 2019-07-25 Sist oppdatert: 2019-07-25bibliografisk kontrollert

Open Access i DiVA

Fulltekst mangler i DiVA

Andre lenker

Forlagets fulltekstPubMedScopus

Søk i DiVA

Av forfatter/redaktør
Xueli, ZhangZhang, Hong
Av organisasjonen
I samme tidsskrift
International Journal of Molecular Sciences

Søk utenfor DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric

doi
pubmed
urn-nbn
Totalt: 120 treff
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf